CN104619330B - 用于治疗伤口和疮的包含次氯酸盐和氨基酸的制剂 - Google Patents

用于治疗伤口和疮的包含次氯酸盐和氨基酸的制剂 Download PDF

Info

Publication number
CN104619330B
CN104619330B CN201380039773.4A CN201380039773A CN104619330B CN 104619330 B CN104619330 B CN 104619330B CN 201380039773 A CN201380039773 A CN 201380039773A CN 104619330 B CN104619330 B CN 104619330B
Authority
CN
China
Prior art keywords
treatment
use according
aqueous component
ulcer
ulcers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201380039773.4A
Other languages
English (en)
Chinese (zh)
Other versions
CN104619330A (zh
Inventor
乌尔丽卡·阿姆郝德
卡林·布尔维斯特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RLS Global AB
Original Assignee
RLS Global AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RLS Global AB filed Critical RLS Global AB
Publication of CN104619330A publication Critical patent/CN104619330A/zh
Application granted granted Critical
Publication of CN104619330B publication Critical patent/CN104619330B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CN201380039773.4A 2012-07-24 2013-07-15 用于治疗伤口和疮的包含次氯酸盐和氨基酸的制剂 Expired - Fee Related CN104619330B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1250891A SE536581C2 (sv) 2012-07-24 2012-07-24 Ett kit för behandling av sår eller liknande och ett preparat och metoder därav
SE1250891-7 2012-07-24
PCT/EP2013/064919 WO2014016157A1 (en) 2012-07-24 2013-07-15 Preparation for treatment of wounds and sores comprising hypochlorite and amino acids

Publications (2)

Publication Number Publication Date
CN104619330A CN104619330A (zh) 2015-05-13
CN104619330B true CN104619330B (zh) 2018-01-19

Family

ID=48783266

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380039773.4A Expired - Fee Related CN104619330B (zh) 2012-07-24 2013-07-15 用于治疗伤口和疮的包含次氯酸盐和氨基酸的制剂

Country Status (9)

Country Link
US (1) US9999605B2 (enExample)
EP (2) EP3299022A1 (enExample)
JP (1) JP6169693B2 (enExample)
CN (1) CN104619330B (enExample)
CA (1) CA2879362C (enExample)
ES (1) ES2657598T3 (enExample)
MX (1) MX360207B (enExample)
SE (1) SE536581C2 (enExample)
WO (1) WO2014016157A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE536581C2 (sv) 2012-07-24 2014-03-11 Rls Global Ab Ett kit för behandling av sår eller liknande och ett preparat och metoder därav
AU2014343506C1 (en) 2013-10-29 2023-06-01 Hypo-Stream Limited Anti-inflammatory solution comprising sodium hypochlorite
GB2519774A (en) * 2013-10-29 2015-05-06 Hypo Stream Ltd Anti-inflammatory solution
EP3703805A4 (en) * 2017-10-31 2021-07-28 Otomagnetics, Inc. MAGNETICALLY ASSISTED ADMINISTRATION IN AND THROUGH THE SKIN
RU2684415C1 (ru) * 2018-04-18 2019-04-09 Федеральное государственное бюджетное образовательное учреждение высшего образования Кубанский государственный медицинский университет Министерства здравоохранения Российской Федерации, ФГБОУ ВО КубГМУ МЗ РФ Способ лечения гнойных ран
JP2022548928A (ja) * 2019-09-19 2022-11-22 アールエルエス グローバル アーベー Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ｅｐｉｄｅｒｍｉｄｉｓに関連する感染症の除去および／または予防のための調製物
RU2741954C1 (ru) * 2020-07-20 2021-02-01 Государственное бюджетное учреждение здравоохранения "Научно-исследовательский институт - краевая клиническая больница N 1 имени профессора С.В. Очаповского" Министерства здравоохранения Краснодарского края (ГБУЗ "НИИ-ККБ N 1 им. проф. Очаповского" Минздрава Краснодарского края) Способ лечения локальных ран головы с остеонекрозом костей свода черепа

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1418193A (en) 1973-03-14 1975-12-17 Wilkinson Sword Ltd Dispenser for hypochlorite gels
US3950536A (en) 1974-02-01 1976-04-13 Sol Joseph Barer N,N-Dichloro substituted aminocarboxylic acids as bactericides and fungicides
JPH0233013B2 (ja) 1980-03-21 1990-07-25 Masatoshi Fumiiri Sokonchiryozai
GB8324487D0 (en) 1983-09-13 1983-10-12 Geistlich Soehne Ag Topically administrable pharmaceutical compositions
SE507437C2 (sv) 1996-11-14 1998-06-08 Medi Team Dentalutveckling I G Preparat för användning vid kemisk-mekanisk behandling av kariesangrepp och förfarande för framställning av preparatet
JPH10175857A (ja) * 1996-12-19 1998-06-30 Sekisui Chem Co Ltd 創傷治療剤
DK1059934T3 (da) 1998-02-27 2002-11-11 Biora Bioex Ab Matrixproteinpræparater til sårheling
US6846478B1 (en) 1998-02-27 2005-01-25 The Procter & Gamble Company Promoting whole body health
US6350438B1 (en) 1998-02-27 2002-02-26 The Procter & Gamble Company Oral care compositions comprising chlorite and methods
FR2819723B1 (fr) 2001-01-23 2006-11-17 Arnaud Mainnemare Composition halogene, son procede de preparation et ses utilisations
US20030194445A1 (en) * 2001-11-12 2003-10-16 Kuhner Carla H. Compositions and methods of use of peptides in combination with biocides and/or germicides
AU2003279165A1 (en) 2002-10-07 2004-05-04 Alcide Corporation Acidified chlorite compositions containing nitrogenous stabilizers and systems and methods related thereto
PL1656095T3 (pl) 2003-08-18 2014-04-30 Novabay Pharmaceuticals Inc N,n-dwuchlorowcowane kwasy aminowe i pochodne
US7423064B2 (en) * 2004-09-24 2008-09-09 Olatec Industries, Llc Composition for treating bacterial, viral, fungal diseases, inflammation and pain
TWI386201B (zh) 2005-01-25 2013-02-21 Novabay Pharmaceuticals Inc Ｎ-鹵化胺基酸、ｎ，ｎ-二鹵化胺基酸與其衍生物；以及使用其之組合物與方法
US20070032754A1 (en) * 2005-08-02 2007-02-08 Walsh Richard F Method and apparatus for treating a wound
TW200843787A (en) 2006-12-29 2008-11-16 Novabay Pharmaceuticals Inc N-halogenated amino compounds and derivatives; compositions and methods of using them
KR20080082742A (ko) 2007-03-09 2008-09-12 이향락 충치 제거제
UY31058A1 (es) 2007-05-01 2008-10-31 Alcon Res Ltd Formulaciones de aminoacido n-halogenado con compuestos antiinflamatorios
US7879798B1 (en) 2007-08-24 2011-02-01 Regenicel, Inc. Composition for indolent wound healing and methods of use therefor
UY31055A1 (es) 2008-02-01 2008-10-31 Alcon Res Ltd Sales antimicrobianas de aminoacido n-halogenado
WO2010017405A1 (en) 2008-08-06 2010-02-11 Adam Heller Methods and compositions for the treatment of pain
WO2010091280A1 (en) 2009-02-06 2010-08-12 Alcon Research, Ltd. N-halogenated amino acid formulations comprising phosphine or amine oxides
JP5587969B2 (ja) 2009-03-18 2014-09-10 オラテック インダストリーズ リミティド ライアビリティ カンパニー 炎症及び疼痛の処置用の化合物
US20110020474A1 (en) 2009-07-27 2011-01-27 Novabay Pharmaceuticals, Inc. Methods of Treating Infections of the Nail or Skin Using Hypohalite
CN102573500A (zh) 2009-08-06 2012-07-11 纽拉尔图斯制药公司 巨噬细胞相关疾病的治疗
US8486155B2 (en) * 2010-05-13 2013-07-16 Ethicon Endo-Surgery, Inc. Fistula repair plug having multiple layers
EP2510944A1 (en) 2011-04-15 2012-10-17 National University of Ireland, Galway Treatment of bacterial infections
CA3254125A1 (en) * 2011-10-08 2025-07-08 Next Science IP Holdings Pty Ltd Antimicrobial compositions and methods employing same
SE536581C2 (sv) 2012-07-24 2014-03-11 Rls Global Ab Ett kit för behandling av sår eller liknande och ett preparat och metoder därav

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
A randomised, controlled and blinded histological and immunohistochemical investigation of Carisolve on pulp tissue;C. Young et al.;《Journal of Dentistry》;20011231;第29卷;275-281 *
Eusol;DAVID J LEAPER;《BMJ》;19920411;第304卷;930-931页 *
The use of topical, un-buffered sodium hypochlorite in the management of burn wound infection;E. Coetzee et al.;《BURNS》;20120630;第38卷;529–533页 *

Also Published As

Publication number Publication date
CN104619330A (zh) 2015-05-13
ES2657598T3 (es) 2018-03-06
US9999605B2 (en) 2018-06-19
EP3299022A1 (en) 2018-03-28
MX2015001019A (es) 2015-04-08
MX360207B (es) 2018-10-24
JP6169693B2 (ja) 2017-07-26
WO2014016157A1 (en) 2014-01-30
EP2877188B1 (en) 2017-10-25
CA2879362A1 (en) 2014-01-30
US20150174091A1 (en) 2015-06-25
SE1250891A1 (sv) 2014-01-25
SE536581C2 (sv) 2014-03-11
JP2015522632A (ja) 2015-08-06
CA2879362C (en) 2020-09-22
EP2877188A1 (en) 2015-06-03

Similar Documents

Publication Publication Date Title
CN104619330B (zh) 用于治疗伤口和疮的包含次氯酸盐和氨基酸的制剂
KR102132543B1 (ko) 양이온성 살생물제를 포함하는 페트롤라툼-계 조성물
CN105142728B (zh) 用于治疗表面创伤的组合物和方法
JP5002114B2 (ja) 亜塩素酸塩および過酸化水素を含有する相乗的抗菌性眼科用および皮膚科用製剤
US20100284951A1 (en) Novel compositions for the treatment of wounds and skin care
EP3164139B1 (en) Topical compositions and methods for treating wounds
WO2010079209A2 (en) Compositions for treating wounds and skin conditions
US20040147534A1 (en) Topical composition and method for treating occlusive wounds
RU2146136C1 (ru) Антисептическое средство "катацел"
MX2011009935A (es) Crema medicinal para dermatitis del pañal y un proceso para hacerla.
US10285938B2 (en) Composition for the treatment of burns, diabetic wounds, other types of wounds and subsequently greatly reduced scarring
EP3087990B1 (en) Gel-forming powder comprising sulfamonomethoxine and chitosan for treating wounds
JP7441943B2 (ja) 細菌感染および創傷治癒のための医薬組成物を含む局所的抗生物質
US20240382517A1 (en) Topical Pharmaceutical Skin Composition for the Delivery of Nitric Oxide in Combination with Other Topical Dermatologic Agents
KR20100008276A (ko) 실리콘 입자를 포함하는 드레싱 재제 및 그 제조 방법
Gressida et al. A Rare Case of a Second-Degree Chemical Burn due to Successive Contacts of Acidic Wart Removal Solution and Paint Solution
CN119403561A (zh) 用于预防和治疗潮湿相关性皮肤损伤的组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20180119

CF01 Termination of patent right due to non-payment of annual fee